The present invention relates to crystalline free base compound having the following formula: wherein R is an unsubstituted pyridyl methyl group or a pyridyl methyl group substituted by a hydroxy methyl group; or a pharmaceutically acceptable salt or a solvate thereof.

 
Web www.patentalert.com

< Substituted fused heterocyclic C-glycosides

< Avermectin b1 monosaccharide derivatives

> Silencing of tgf-beta receptor type II expression by sirna

> Human G-protein coupled receptor, HGPRBMY11, and variants thereof

~ 00294